PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.25%
Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.
42.84%
Cost growth of 42.84% versus flat Healthcare costs. Walter Schloss would verify cost control.
-11.81%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-11.59%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
10.45%
R&D change of 10.45% versus flat Healthcare spending. Walter Schloss would verify adequacy.
71.57%
G&A change of 71.57% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
3.83%
Marketing expense change of 3.83% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-11.93%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
31.72%
Operating expenses growth exceeding 1.5x Healthcare median of 0.97%. Jim Chanos would check for waste.
34.31%
Total costs growth exceeding 1.5x Healthcare median of 1.34%. Jim Chanos would check for waste.
334.21%
Interest expense change of 334.21% versus flat Healthcare costs. Walter Schloss would verify control.
12.61%
D&A growth exceeding 1.5x Healthcare median of 0.74%. Jim Chanos would check for overinvestment.
-156.43%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-598.40%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1070.05%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1072.51%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
1252.78%
Other expenses growth exceeding 1.5x Healthcare median of 1.80%. Jim Chanos would check for issues.
433.16%
Income change of 433.16% versus flat Healthcare. Walter Schloss would verify quality.
434.51%
Margin change of 434.51% versus flat Healthcare. Walter Schloss would verify quality.
-6370.24%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
433.16%
Income change of 433.16% versus flat Healthcare. Walter Schloss would verify quality.
434.51%
Margin change of 434.51% versus flat Healthcare. Walter Schloss would verify quality.
306.74%
EPS growth exceeding 1.5x Healthcare median of 2.57%. Joel Greenblatt would investigate advantages.
306.74%
Diluted EPS growth exceeding 1.5x Healthcare median of 2.53%. Joel Greenblatt would investigate advantages.
17.10%
Share count reduction below 50% of Healthcare median of 0.20%. Jim Chanos would check for issues.
16.43%
Diluted share reduction below 50% of Healthcare median of 0.27%. Jim Chanos would check for issues.